Skip to main content

Table 1 HIV-1 Subtypes and Antiretroviral Drug Mutations in Twenty-Seven Beninese-Naive Patients

From: Moderate rate of transmitted resistance mutations to antiretrovirals and genetic diversity in newly HIV-1 patients diagnosed in Benin

Samples ID

Age (years)

Viral load (Log10)

Drug Resistance Mutations Associated

HIV-1 subtypes

PI*

NRTI*

NNRTI*

NRTI + NNRTI*

Ben148

31

5.52

K103N

URF (CRF02_AG/A3)

Ben 784

34

4.31

K103N

CRF02_AG

Ben 538

42

5.81

M184V

G

Ben 169

33

6.2

G190A

URF (CRF06_cpx/A)

Ben 18

36

5.04

I85V

CRF02_AG

Ben 226

35

5.7

K103N

A3

Ben 230

25

5.37

K103N

CRF02_AG

Ben 232

20

6.57

M184V

URF (CRF02_AG/A1)

Ben 255

30

5.39

K103N

CRF02_AG

Ben 722

29

5.28

D67N

K103N

D67N, K103N

CRF02_AG

Ben 607

40

3.45

M184V

V106A, G190A

M184V, V106A, G190A

G

Ben 96

31

5.85

L90M

CRF02_AG

Ben 98

43

4.97

K103N

CRF06_cpx

Ben 687

28

5.28

M41L

K103N

M41L, K103N

URF (CRF06_cpx/CRF02_AG)

Ben 420

25

631

M184V

URF (CRF06_cpx/CRF02_AG/A3)

Ben 643

20

5.54

Y188L

CRF02_AG

Ben 657

42

5.6

T215S

CRF02_AG

Ben 206

41

5.27

K103N, P225H

CRF02_AG

Ben 208

26

4.99

M184V

CRF02_AG

Ben 211

51

4.31

K103N

CRF02_AG

Ben 212

35

4.18

K65R, M184I

K103N, Y188L

K65R, M184I, K103N, Y188L

CRF02_AG

Ben 213

35

5.58

M184V

Y181C

M184V, Y181C

G

Ben 214

45

5.97

K103N

CRF02_AG

Ben 216

37

6.68

M184V

URF (CRF02_AG/U)

Ben 218

52

5.06

K103N

A3

Ben 390

52

5.67

K103N

CRF02_AG

Ben 101

45

5.39

D67G, K70R, M184V K219Q

V106M, Y181C, G190A

D67G, K70R, M184V, K219Q

V106M, Y181C, G190A

G

  1. NRTI nucleoside reverse transcriptase inhibitors, NNRTI nonnucleoside reverse transcriptase inhibitors, PI protease inhibitors, URF unique recombinant forms, Ben Benin
  2. *According to the WHO algorithm for Surveillance of Drug Resistance Mutations (SDRM), 2009